Publications:

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient.

Frontiers In Pharmacology

Fu, Yang Y; Zheng, Yue Y; Wang, Pei-Pei PP; Chen, Yue-Yun YY; Ding, Zhen-Yu ZY

Publication Date: 2022

Variant appearance in text: POLE: V1002A

PubMed Link: 35308232

Variant Present in the following documents:

• Main text
• fphar-13-817265.pdf

View BVdb publication page

Finding driver mutations in cancer: Elucidating the role of background mutational processes.

Plos Computational Biology

Brown, Anna-Leigh AL; Li, Minghui M; Goncearenco, Alexander A; Panchenko, Anna R AR

Publication Date: 2019-04

Variant appearance in text: POLE: V1002A

PubMed Link: 31034466

Variant Present in the following documents:

• pcbi.1006981.s010.xlsx, sheet 1

View BVdb publication page

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.

Cancer Discovery

Johanns, Tanner M TM; Miller, Christopher A CA; Dorward, Ian G IG; Tsien, Christina C; Chang, Edward E; Perry, Arie A; Uppaluri, Ravindra R; Ferguson, Cole C; Schmidt, Robert E RE; Dahiya, Sonika S; Ansstas, George G; Mardis, Elaine R ER; Dunn, Gavin P GP

Publication Date: 2016-11

Variant appearance in text: POLE: V1002A

PubMed Link: 27683556

Variant Present in the following documents:

• Main text

View BVdb publication page